Fennec Pharmaceuticals Inc. Common Stock FENC
$12.17
+3.93%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $17.00
- Implied Upside
- +39.7%
- Price Target Range
- $16.00 – $18.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-12 | B. Riley SecuritiesMadison El-Saadi |
Reiterates | Buy | $16 → $18 |
| 2026-08-12 | WedbushDavid Nierengarten |
Maintains | Outperform | $13 → $16 |
| 2026-05-22 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $13 → $16 |
| 2026-04-16 | WedbushDavid Nierengarten |
Reiterates | Outperform | $13 |
| 2026-01-09 | Piper SandlerDavid Amsellem |
Initiates coverage on | Overweight | $18 |
| 2025-08-21 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $13 |
| 2025-08-15 | Craig-HallumChase Knickerbocker |
Maintains | Buy | $13 → $14 |
| 2025-05-20 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $13 |
| 2025-05-14 | Craig-HallumChase Knickerbocker |
Maintains | Buy | $12 → $13 |
| 2025-03-11 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $13 |
| 2024-12-17 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $13 |
| 2024-08-22 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $15 → $13 |
| 2024-08-14 | Craig-HallumChase Knickerbocker |
Maintains | Buy | $17 → $15 |
| 2024-05-15 | Craig-HallumChase Knickerbocker |
Maintains | Buy | $20 → $17 |
| 2024-05-15 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $18 → $15 |
| 2024-04-04 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $17 → $18 |
| 2024-03-18 | Craig-HallumChase Knickerbocker |
Maintains | Buy | $17 → $18 |
| 2023-08-04 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $18 → $17 |
| 2023-06-21 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $18 |
| 2023-04-06 | Cantor FitzgeraldCharles Robertson II |
Maintains | Overweight | $12 → $16 |
| 2023-04-04 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $18 |
| 2023-03-31 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $18 |
| 2023-01-26 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $18 |
| 2022-11-22 | Cantor FitzgeraldCharles Duncan |
Upgrades | Neutral → Overweight | $9 → $12 |
| 2022-10-20 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $14 → $18 |
| 2022-09-26 | WedbushDavid Nierengarten |
Maintains | Outperform | $11 → $19 |
| 2022-09-07 | Capital OneNaureen Quibria |
Initiates coverage on | Overweight | $11 |
| 2022-08-08 | Craig-HallumChase Knickerbocker |
Assumes | Buy | $14 |
| 2021-06-03 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $15 → $14 |
| 2021-04-21 | Craig-HallumRobin Garner |
Initiates coverage on | Buy | $17 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $12.17
- Market Cap
- $410.64 million
- 52-Week Range
- $5.65 – $13.25
- Average Volume
- 183K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.